Medical/Pharmaceuticals

BIOTRONIK, Charité, and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology

Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology BERLIN, May 19, 2026 /PRNewswire/ -- BIOTRONIK, die Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation today announced a research and innovation partnership focused on advancing digital and tr...

2026-05-19 14:00 3280

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

* IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. * Maximum dose reached with no dose-limiting toxicities observed. * TLX101-Tx is also the subject of a pivotal trial, IPAX BrIGHT, which is actively dosing patients with recurrent glioblastoma. MELBOURNE, Australia ...

2026-05-19 05:00 4208

Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing

NORWALK, Conn., May 19, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, today announced that it has led Violet Therapeutics' $4.75 million seed extension financing, with participation from Dementia Discovery Fund, UTEC...

2026-05-19 01:03 2932

MS Pharma Announces Strategic Growth Investment from Olayan Financing Company

Strategic Partnership to Accelerate Growth in Saudi Arabia and Across the MENA Region AMMAN, Jordan and RIYADH, Saudi Arabia, May 18, 2026 /PRNewswire/ -- MS Pharma today announced that Olayan Financing Company (OFC) has made a minority equity investment in the company. This partnership brings s...

2026-05-18 20:39 2852

Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease

* Congenital adrenal hyperplasia (CAH) and Cushing's disease (CD) are rare disorders characterized by excess adrenocorticotropic hormone (ACTH) produced in the brain1,2 * Current treatments are limited by suboptimal disease control and treatment-related complications3,4 * Asedebart (Lu AG13...

2026-05-18 17:10 2913

PolyU collaborates with global scholars and experts to promote modern healthcare and wellness

Close to 100 participants experience Taichi and Qigong HONG KONG, May 18, 2026 /PRNewswire/ -- The Research Centre for Chinese Medicine Innovation (RCMI) of The Hong Kong Polytechnic University (PolyU) hosted the "Symposium on Martial Arts: Bridging Art and Science" and two "Health Cultivation W...

2026-05-18 14:53 3592

Johnson & Johnson Launches 'Gut Tunnel' Experience in Singapore to Highlight the Importance of Endoscopic Remission in IBD

New data presented at Digestive Disease Week 2026 reinforces endoscopic remission as being associated with long-term patient outcomes,[1],[2] yet more than 60% of people with IBD have not heard of this key treatment goal.[3],[4] Anchoring World IBD Day, the interactive Gut Tunnel installation...

2026-05-18 10:00 3069

Malaysia Healthcare Week Myanmar 2026 Opens in Yangon with Leading Hospitals Showcasing Specialised Care for Myanmar Patients

YANGON, Myanmar and KUALA LUMPUR, Malaysia, May 15, 2026 /PRNewswire/ -- Malaysia Healthcare Week Yangon 2026 is officially launched today at Park Royal Yangon, bringing together leading Malaysian hospitals to connect directly with Myanmar patients, healthcare professionals, and industry partners...

2026-05-15 22:04 7951

Ozelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis

BERLIN, May 15, 2026 /PRNewswire/ -- Ozelle has received a Gold Award at theGerman Innovation Award , one of Germany...

2026-05-15 14:00 3658

Herbalgy Trophy & "Goal-Getter Giveaway" - A Triumphant Return

Spend HK$180 Unlocks Your Shot at Over HK$1M in Match Tickets – 1,000 Tickets to Chelsea FC vs. Juventus at Kai Tak Buy More, Enter More HONG KONG, May 15, 2026 /PRNewswire/ -- Football fans can now experience the thrill of Chelsea FC vs Juventus live — no trip to Europe required. Pain managemen...

2026-05-15 09:00 3128

NeuroEndocrine Cancer Australia unveils new website and digital lifeline

NeuroEndocrine Cancer Australia (NECA) has launched a fully updated digital platform designed to improve how the 31,000 Australians affected by neuroendocrine cancer (NETs) access support, information, and specialist care. SYDNEY, May 15, 2026 /PRNewswire/ -- The new website introduces a persona...

2026-05-15 07:00 2648

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence NASHIK, India, May 14, 2026 /PRNewswire/ -- Datar Cancer Genetics (DCG), a global precision oncology company, today announced that ...

2026-05-14 23:58 3842

CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT

The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration BOSTON, May 14, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network, today announced that the German-based but globally active CHEPLAPHAR...

2026-05-14 22:00 3551

Applications Open for Second Annual Asia-Pacific Global Health Innovation Hackathon on Maternal & Child Nutrition

12 teams, 48 Hours. Innovating for a healthier, more equitable Asia-Pacific SINGAPORE, May 14, 2026 /PRNewswire/ -- Applications are now open for the second annual Asia-Pacific Global Health Innovation Hackathon, to be held in Singapore on 18–19 September 2026. Jointly co-hosted by two SingHealth...

2026-05-14 17:28 5152

Breakthrough skin-tightening device XERF™ arrives in Australia

The new radiofrequency treatment, XERF, is designed to target multiple layers of the skin while prioritizing patient comfort. SYDNEY, May 14, 2026 /PRNewswire/ -- Cynosure Lutronic's XERF is a radiofrequency-based treatment designed to tighten and revitalise skin without the need for needles, nu...

2026-05-14 16:50 3548

Wellcome launches world's largest global prize for mental health science

* The prize, in partnership with Nature, will celebrate breakthroughs in mental health science. It aims to accelerate translation, influence policy and transform lives * This award champions new pharmacological, psychological, social and digital interventions from around the world * The ...

2026-05-14 16:00 2748

SingPost and Fullerton Health to Collaborate on Healthcare Logistics and Last-Mile Medical Delivery

SINGAPORE, May 14, 2026 /PRNewswire/ -- Singapore Post Limited ("SingPost") and Fullerton Healthcare Group Private Limited ("Fullerton Health") have today announced the signing of a Memorandum of Understanding ("MOU") to explore the co-development of a robust, integrated healthcare delivery ecosy...

2026-05-14 15:24 2755

GenesisCare and SeeTreat to bring personalised Offline Adaptive Monitoring to more than 40 radiation oncology centres across Australia

SYDNEY, May 14, 2026 /PRNewswire/ -- Leading Australian cancer care provider, GenesisCare, is pleased to be collaborating with SeeTreat to enable suitable cancer patients access to the latest technology in offline adaptive treatment assessment. SeeTreat's ART.1 software will be rolled out at Gene...

2026-05-14 15:00 3375

Singapore's First Immersive Installation on the Cycles of Intergenerational Harm Opens at One Punggol This May

Why Hurt Children Hurt Children invites Singaporeans to step inside The Black Box — a confrontational, compassionate experience addressing the emotional harm that passes silently from one generation to the next SINGAPORE, May 14, 2026 /PRNewswire/ -- EveryChild.SG, Singapore's movement for child...

2026-05-14 12:11 3665

MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control

- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application (BLA) scheduled for 2H 2026 SEOUL, South Korea and...

2026-05-14 10:30 3534
1234567 ... 392